Chemours (CC)

• Market cap: $2.9B
• 1 day: 1.62%
• 5 days: 9.85%
• 1 month: 6.53%
• 3 months: -1.82%
• 6 months: -21.04%
• Year to date: 16.10%
• 1 year: -32.71%
• 5 years: 11.11%
• 10 years: -6.95%
• Sector: Materials
• Industry: Chemicals & Allied Products

About: The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Employees: 6,200

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 6 (+3) [Q3]

34% more call options, than puts

Call options by funds: $39M | Put options by funds: $29.1M

9% more repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 114

0.78% more ownership

Funds ownership: 81.77% [Q2] → 82.55% (+0.78%) [Q3]

4% less funds holding

Funds holding: 434 [Q2] → 416 (-18) [Q3]

9% less capital invested

Capital invested by funds: $2.75B [Q2] → $2.5B (-$244M) [Q3]

18% less first-time investments, than exits

New positions opened: 62 | Existing positions closed: 76

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $21 8% upside
• Avg. target: $22 15% upside
• High target: $25 29% upside

5 analyst ratings

• positive: 1 20%
• neutral: 4 80%
• negative: 0 0%

Morgan Stanley Vincent Andrews 80% 1-year accuracy 4 / 5 met price target	13% upside $22	Equal-Weight Maintained	13 Jan 2025
Mizuho John Roberts 53% 1-year accuracy 20 / 38 met price target	8% upside $21	Neutral Maintained	7 Jan 2025
Goldman Sachs Duffy Fischer 69% 1-year accuracy 9 / 13 met price target	8% upside $21	Neutral Maintained	7 Jan 2025
RBC Capital Arun Viswanathan 29% 1-year accuracy 20 / 70 met price target	29% upside $25	Outperform Reiterated	12 Dec 2024
Barclays Michael Leithead 37% 1-year accuracy 7 / 19 met price target	19% upside $23	Equal-Weight Maintained	5 Nov 2024